NBRV(Delisted)
Nabriva Therapeutics·NASDAQ
--
--(--)
NBRV fundamentals
Nabriva Therapeutics (NBRV) released its earnings on Mar 16, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 16, 2018
EPS
Revenue
Revenue & Expenses
NBRV has released its 2023 Q1 earnings report, with revenue of 7.59M, reflecting a YoY change of -5.36%, and net profit of -8.70M, showing a YoY change of 26.39%. The Sankey diagram below clearly presents NBRV's revenue sources and cost distribution.
Key Indicators
Nabriva Therapeutics (NBRV) key financial stats and ratios, covering profitability, financial health, and leverage.
Nabriva Therapeutics (NBRV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Nabriva Therapeutics (NBRV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Nabriva Therapeutics (NBRV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Nabriva Therapeutics (NBRV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Nabriva Therapeutics (NBRV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
